Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

ĎURINÍKOVÁ Anna FOLTA Adam PARDY Filip SVATOŇ Jan DRNCOVÁ Marie WEINBERGEROVÁ Barbora CETKOVSKY Petr RÁČIL Zdeněk JINDRA Pavel SZOTKOWSKI Tomas ZAK Pavel MAYER Jiří JEŽÍŠKOVÁ Ivana

Year of publication 2022
Type Article in Periodical
Magazine / Source LEUKEMIA & LYMPHOMA
MU Faculty or unit

Central European Institute of Technology

Citation
Web https://www.tandfonline.com/doi/abs/10.1080/10428194.2022.2116931?journalCode=ilal20
Doi http://dx.doi.org/10.1080/10428194.2022.2116931
Keywords RAS MUTATIONAMLGENE
Attached files
Description Oncogenic mutation in the NRAS are carried by 10-22% acute myeloid leukemia (AML) patients and represents one of the most commonly detected molecular aberrations in AML.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.